Treating EGFR mutation resistance in non-small cell lung cancer – role of osimertinib

Valentina Mazza, Federico Cappuzzo
  • The Application of Clinical Genetics, July 2017, Dove Medical Press
  • DOI: 10.2147/tacg.s103471

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication

The following have contributed to this page: Dr Federico Cappuzzo